ARCHIVES

Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Day: November 13, 2019

Roche Drug for Spinal Muscular Atrophy

Roche Drug for Spinal Muscular Atrophy Hits Target in Late-Stage Trial

VIA: https://www.reuters.com/article/us-roche-risdiplam-approval/roche-drug-for-spinal-muscular-atrophy-hits-target-in-late-stage-trial-idUSKBN1XL1WL ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on Monday when the Swiss drugmaker said its drug risdiplam improved motor function in

Read More »